Cargando…

Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a destructive disease with a poor prognosis, low survival rate and high rate of metastasis. It comprises 15% of total breast cancers and is marked by deficiency of three important receptor expressions, i.e., progesterone, estrogen, and human epidermal growth f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fatima, Mahak, Sheikh, Afsana, Abourehab, Mohammed A. S., Kesharwani, Prashant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695386/ https://www.ncbi.nlm.nih.gov/pubmed/36365249 http://dx.doi.org/10.3390/pharmaceutics14112432

Ejemplares similares

Dostarlimab as a Miracle Drug: Rising Hope against Cancer Treatment
por: Singh, Vanshikha, et al.
Publicado: (2022)

CD44-Targeted Nanocarrier for Cancer Therapy
por: Kesharwani, Prashant, et al.
Publicado: (2022)

Gold nanoparticles and gold nanorods in the landscape of cancer therapy
por: Kesharwani, Prashant, et al.
Publicado: (2023)

Amelioration of Full-Thickness Wound Using Hesperidin Loaded Dendrimer-Based Hydrogel Bandages
por: Gupta, Praveen, et al.
Publicado: (2022)

Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer
por: Liu, Zhe, et al.
Publicado: (2023)

Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer
por: Pradhan, Rajesh, et al.
Publicado: (2023)

Itraconazole and Difluorinated-Curcumin Containing Chitosan Nanoparticle Loaded Hydrogel for Amelioration of Onychomycosis
por: Kesharwani, Prashant, et al.
Publicado: (2022)

Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
por: Sheikh, Afsana, et al.
Publicado: (2022)

Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery
por: Narwade, Mahavir, et al.
Publicado: (2023)

Advances in Functionalized Photosensitive Polymeric Nanocarriers
por: Fernández, Maritza, et al.
Publicado: (2021)

Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier
por: Ma, Weina, et al.
Publicado: (2020)

A Review on Nanocarrier Mediated Treatment and Management of Triple Negative Breast Cancer: A Saudi Arabian Scenario
por: Nahvi, Insha, et al.
Publicado: (2022)

Optimizing the Pharmacological Properties of Discoidal Polymeric Nanoconstructs Against Triple-Negative Breast Cancer Cells
por: Ferreira, Miguel, et al.
Publicado: (2020)

Polymeric Nanocarriers for the Delivery of Antimalarials
por: Mhlwatika, Zandile, et al.
Publicado: (2018)

Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
por: Hasan, Nazeer, et al.
Publicado: (2023)

Advancements in nanoparticle-based treatment approaches for skin cancer therapy
por: Zeng, Leli, et al.
Publicado: (2023)

Niclosamide encapsulated polymeric nanocarriers for targeted cancer therapy
por: Jain, Nishant Kumar, et al.
Publicado: (2019)

Polymeric nanocarrier systems for photodynamic therapy
por: Li, Li, et al.
Publicado: (2014)

Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics
por: Gajbhiye, Kavita R., et al.
Publicado: (2023)

Encapsulating Halofuginone Hydrobromide in TPGS Polymeric Micelles Enhances Efficacy Against Triple-Negative Breast Cancer Cells
por: Zuo, Runan, et al.
Publicado: (2021)

The anti‐cancer effect of chitosan/resveratrol polymeric nanocomplex against triple‐negative breast cancer; an in vitro assessment
por: Bozorgi, Azam, et al.
Publicado: (2022)

Cascade Release Nanocarriers for the Triple-Negative Breast Cancer Near-Infrared Imaging and Photothermal-Chemo Synergistic Therapy
por: Li, Ke, et al.
Publicado: (2021)

Recent advances in targeted strategies for triple-negative breast cancer
por: Zhu, Shuangli, et al.
Publicado: (2023)

Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy
por: Guan, Qixiao, et al.
Publicado: (2021)

Polymeric nanocarriers for the treatment of systemic iron overload
por: Hamilton, Jasmine L, et al.
Publicado: (2015)

Polymeric Nanocarriers: A Transformation in Doxorubicin Therapies
por: Butowska, Kamila, et al.
Publicado: (2021)

Polymeric nanocarriers as stimuli-responsive systems for targeted tumor (cancer) therapy: Recent advances in drug delivery
por: Alsehli, Mosa
Publicado: (2020)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
por: Fleisher, Brett, et al.
Publicado: (2016)

Recent advances in managing triple-negative breast cancers
por: Bengala, Carmelo
Publicado: (2009)

Triple-negative breast cancer: recent treatment advances
por: Bergin, Alice R T, et al.
Publicado: (2019)

The advance of adjuvant treatment for triple-negative breast cancer
por: Ge, Jingyu, et al.
Publicado: (2022)

Correction: Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Dual Regulation of miR-34a and Notch Signaling in Triple-Negative Breast Cancer by Antibody/miRNA Nanocarriers
por: Valcourt, Danielle M., et al.
Publicado: (2020)

Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy
por: Song, Mingming, et al.
Publicado: (2021)

Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
por: Avramović, Nataša, et al.
Publicado: (2020)

Drug Delivery with Polymeric Nanocarriers—Cellular Uptake Mechanisms
por: Nelemans, Levi Collin, et al.
Publicado: (2020)

Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer
por: Liu, Siyan, et al.
Publicado: (2022)

MTX-PEG-modified CG/DMMA polymeric micelles for targeted delivery of doxorubicin to induce synergistic autophagic death against triple-negative breast cancer
por: Cao, Zhiwen, et al.
Publicado: (2023)

Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy
por: Misra, Ranjita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1j93b7jpj800d5ut64idrf039h